VHL and nonpapillary renal cell carcinoma: In agreement with our hypothesis, VHL too ranked as the most dominant driver in ccRCC (Supplementary Fig. 14), when we applied the same “driver dominance” metric to exome-wide mutation data from the TCGA ccRCC cohort42.